BMO Capital reiterates Eli Lilly (LLY) at Outperform on Morphic deal, 'a positive for Lilly shares'
Go back to BMO Capital reiterates Eli Lilly (LLY) at Outperform on Morphic deal, 'a positive for Lilly shares'| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1209.00 -11.28 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1220.28 | 52 Week High | $88.16 | |||
| Open | $1238.30 | 52 Week Low | $67.88 | |||
| Day High | $1240.10 | P/E | 279.86 | |||
| Day Low | $1206.00 | EPS | $4.32 | |||
| Volume | 1,926,717 | |||||
| Temoris Resources, Inc. (NASDAQ: MORF) | Delayed: 56.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.99 | 52 Week High | $0.14 | |||
| Open | $56.99 | 52 Week Low | $0.14 | |||
| Day High | $56.99 | P/E | N/A | |||
| Day Low | $56.99 | EPS | $0.00 | |||
| Volume | 256,427 | |||||
